BSEKerala Ayurveda LtdMediumPositive
Announced Mon, 25 May · 20:59 IST

Press Release

Guidance RaisedBusiness Updates View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.6%1-day move
₹211.40
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.6-8.6-11.6-15.6-17.0-15.8-12.5-13.0-26.1
Up moveDown movePending
AI summary

Kerala Ayurveda reported FY26 total revenue of Rs.145.4 Crs, up 19% YoY (22% excluding discontinued Nutraveda business). Standalone revenue crossed Rs.100 Crs for the first time, growing 32.8%, driven by India D2C e-commerce which surged 270%+ with 6X unit volume growth. Consolidated EBITDA was -Rs.3.5 Crs but adjusted EBITDA (excluding ESOP) turned positive at +Rs.1.8 Crs, with EBITDA margin improving 20 bps to -2.4%. PAT was -Rs.16.3 Crs vs -Rs.14 Crs prior year due to higher interest costs. The company announced full consolidation of Ayurvedagram resort by acquiring the remaining 26% stake via preferential share issue, merging it into the parent. Capital funding has been delayed but is expected to close this financial year.

Likely market impact

The raised FY27 guidance (50% operating revenue growth to Rs.200 Crs) signals strong management confidence but investors should note the company is still loss-making with negative EBITDA and heavy investment plans (3X marketing spend), and break-even is not targeted until January 2027.